Jali Titi is an app that’s being developed as part of a Ripple Scale Challenge cohort.
Help apps like this get to the people who need them by investing in Ripple Scale.

Jali Titi

Black women are less likely to survive breast cancer. Jali Titi is changing that.

Breast screening uptake among Black women is significantly lower than among white women, contributing to delayed diagnoses and poorer outcomes. Black women are more likely to be diagnosed with advanced breast cancer. Low awareness, fear of diagnosis, cultural stigma, and mistrust of healthcare professionals are the documented barriers. These are not individual failings. They are the predictable result of a health system that has historically failed to design for or communicate effectively with Black communities.

Developed by Dr Fiona Okonjo and Dr Flora Kogera, Jali Titi is an inclusive, multilingual breast health app helping Black women understand breast changes across all life stages, from puberty to menopause. Co-designed with users and backed by clinical expertise, it delivers trusted, culturally relevant content to build awareness, reduce fear, and support earlier detection.

“Our vision for Jali Titi is to give Black women access to trusted, culturally relevant breast health information throughout every stage of life, helping them feel informed, empowered and confident to seek care when they need it. With this we hope to see more Black women diagnosed earlier, treated sooner and given the best possible chance of a positive outcome.”

Don't invest unless you're prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

The app includes language selection for accessibility across communities, life stage selection for tailored content, a guided self-check tracker with step-by-step examination guidance and reminders, a personalised health insights dashboard, culturally sensitive educational content in audio and visual formats and a symptom report export for sharing with healthcare professionals.

Jali Titi addresses one of the most persistent inequities in cancer outcomes through a co-designed, culturally grounded digital tool. Dr Okonjo and Dr Kogera have the scientific expertise, the clinical experience, and the community connection to make it work.

FOUNDERS

Dr Fiona Okonjo and Dr Flora Kogera
Jali Titi

Dr Fiona Okonjo holds a doctorate from King's College London, where she discovered a new targeted therapy for breast cancer, and conducted postdoctoral research at the University of Oxford on a novel gene signature in the disease. She has consulted for the WHO on In Vitro Diagnostic regulation and co-developed the first health-tech regulatory sandbox blueprint in Kenya.

Dr Flora Kogera is a GP trainee with over seven years of multidisciplinary experience across obstetrics and gynaecology, breast surgery, paediatrics, and oncology, and has built a health education presence across social media and the web. Together, they are building for communities they are part of and deeply committed to.